Skip to content

Clinical Study on th Treatment of Chronic Pelvic Pain in the Sequela of Pelvic Inflammatory Diseases by Combining Penyan Formula with Acupuncture at Huiyin Point

Clinical Study on th Treatment of Chronic Pelvic Pain in the Sequela of Pelvic Inflammatory Diseases by Combining Penyan Formula with Acupuncture at Huiyin Point

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075579
Enrollment
Unknown
Registered
2023-09-08
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sequela of pelvic inflammatory disease chronic pelvic pain

Interventions

control group:Oral Administration of Traditional Chinese Medicine in Penyan Formula
Treatment group:Oral Administration of Traditional Chinese Medicine in Penyan Formula and acupuncture at Huiyin Point

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: (1) Conforming to the diagnostic standards of Western medicine and traditional Chinese medicine differentiation standards for chronic pelvic pain caused by pelvic inflammatory disease sequelae; (2) Age 20-50 years old; (3) Lower abdominal and lumbosacral pain visual analogue scale (VAS) scores = 3 points; (4) Patients who agree to participate in this study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Pregnant or preparing for pregnancy, lactation, or menopausal women within six months; (2) Those who have been confirmed through examination to have related symptoms caused by other diseases such as endometriosis, adenomyosis, acute cervicitis, specific vaginitis, pelvic venous congestion syndrome, and tuberculous pelvic inflammatory disease; (3) Patients with acute onset of pelvic inflammatory disease or concurrent pelvic abscess, or those with perianal infection; (4) Concomitant cardiovascular disease, liver and kidney disease, hematological system disease, neuropsychiatric disease, etc; (5) Patients with unresolved perineal trauma; (6) A person with needle sickness or a systemic disease that researchers believe requires measures due to discomfort at the injection site.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale;

Secondary

MeasureTime frame
Quality of Life Scale Score;Glazer assessment of pelvic floor muscle strength;Local sign score;Traditional Chinese Medicine Syndrome Score;

Countries

China

Contacts

Public ContactShuyi Feng

Guangdong Provincial Hospital of Traditional Chinese Medicine

493500131@qq.com+86 135 8038 7154

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026